Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001)
Clinical trial NCT01986010 · COMPLETED
Trial details
- NCT number
- NCT01986010
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-25
- Primary completion
- 2016-04-19
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.